Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

DNA methylation profiling as a tool for testicular germ cell tumors subtyping.

Costa AL, Moreira-Barbosa C, Lobo J, Vilela-Salgueiro B, Cantante M, Guimarães R, Lopes P, Braga I, Oliveira J, Antunes L, Henrique R, Jerónimo C.

Epigenomics. 2018 Dec;10(12):1511-1523. doi: 10.2217/epi-2018-0034. Epub 2018 Nov 12.

PMID:
30418048
2.

Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.

Moreira-Barbosa C, Barros-Silva D, Costa-Pinheiro P, Torres-Ferreira J, Constâncio V, Freitas R, Oliveira J, Antunes L, Henrique R, Jerónimo C.

Clin Epigenetics. 2018 Oct 29;10(1):132. doi: 10.1186/s13148-018-0564-2.

3.

Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women.

Nunes SP, Moreira-Barbosa C, Salta S, Palma de Sousa S, Pousa I, Oliveira J, Soares M, Rego L, Dias T, Rodrigues J, Antunes L, Henrique R, Jerónimo C.

Cancers (Basel). 2018 Sep 26;10(10). pii: E357. doi: 10.3390/cancers10100357.

4.

Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival.

Oliveira AI, Xavier-Magalhães A, Moreira-Barbosa C, Magalhães H, Henrique R, Jerónimo C, Costa BM.

Biomark Med. 2018 Mar;12(3):257-264. doi: 10.2217/bmm-2017-0258. Epub 2018 Feb 13.

PMID:
29436234

Supplemental Content

Loading ...
Support Center